Sarissa Capital Management’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $291K | Hold |
|
|||||
|
2024
Q2 | $331K | Hold |
|
|||||
|
2024
Q1 | $533K | Hold |
|
|||||
|
2023
Q4 | $237K | Hold |
|
|||||
|
2023
Q3 | $254K | Hold |
|
|||||
|
2023
Q2 | $272K | Hold |
|
|||||
|
2023
Q1 | $157K | Hold |
|
|||||
|
2022
Q4 | $254K | Hold |
|
|||||
|
2022
Q3 | $315K | Hold |
|
|||||
|
2022
Q2 | $383K | Sell |
|
|||||
|
2022
Q1 | $552K | Hold |
|
|||||
|
2021
Q4 | $583K | Hold |
|
|||||
|
2021
Q3 | $1.28M | Hold |
|
|||||
|
2021
Q2 | $1.51M | Hold |
|
|||||
|
2021
Q1 | $2.89M | Hold |
|
|||||
|
2020
Q4 | $2.5M | Hold |
|
|||||
|
2020
Q3 | $951K | Hold |
|
|||||
|
2020
Q2 | $1.26M | Hold |
|
|||||
|
2020
Q1 | $853K | Hold |
|
|||||
|
2019
Q4 | $1.65M | Hold |
|
|||||
|
2019
Q3 | $1.33M | Hold |
|
|||||
|
2019
Q2 | $2.31M | Buy |
|